Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Annexon (ANNX) EBITDA (2019 - 2026)

Annexon's EBITDA history spans 8 years, with the latest figure at -$44.2 million for Q1 2026.

  • Quarterly EBITDA rose 18.85% to -$44.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$196.5 million through Mar 2026, down 17.38% year-over-year, with the annual reading at -$206.7 million for FY2025, 49.65% down from the prior year.
  • EBITDA came in at -$44.2 million for Q1 2026, up from -$48.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$25.2 million in Q1 2024 to a low of -$54.9 million in Q3 2025.
  • The 5-year median for EBITDA is -$35.6 million (2022), against an average of -$39.1 million.
  • Year-over-year, EBITDA soared 34.51% in 2024 and then tumbled 115.88% in 2025.
  • Annexon's EBITDA stood at -$34.3 million in 2022, then grew by 19.01% to -$27.8 million in 2023, then crashed by 74.9% to -$48.7 million in 2024, then grew by 0.92% to -$48.2 million in 2025, then rose by 8.33% to -$44.2 million in 2026.
  • Per Business Quant, the three most recent readings for ANNX's EBITDA are -$44.2 million (Q1 2026), -$48.2 million (Q4 2025), and -$54.9 million (Q3 2025).